Millennium Management’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $465K | Sell |
171,669
-639,207
| -79% | -$1.73M | ﹤0.01% | 3397 |
|
2025
Q1 | $2.75M | Buy |
810,876
+692,015
| +582% | +$2.35M | ﹤0.01% | 2382 |
|
2024
Q4 | $490K | Buy |
+118,861
| New | +$490K | ﹤0.01% | 3288 |
|
2024
Q2 | – | Sell |
-13,875
| Closed | -$28.6K | – | 4084 |
|
2024
Q1 | $28.6K | Sell |
13,875
-8,992
| -39% | -$18.5K | ﹤0.01% | 3951 |
|
2023
Q4 | $41.2K | Sell |
22,867
-4,283
| -16% | -$7.71K | ﹤0.01% | 3825 |
|
2023
Q3 | $37.2K | Sell |
27,150
-15,852
| -37% | -$21.7K | ﹤0.01% | 3910 |
|
2023
Q2 | $58.9K | Buy |
43,002
+30,397
| +241% | +$41.6K | ﹤0.01% | 3942 |
|
2023
Q1 | $30K | Buy |
+12,605
| New | +$30K | ﹤0.01% | 4287 |
|
2022
Q2 | – | Sell |
-11,951
| Closed | -$47K | – | 5191 |
|
2022
Q1 | $47K | Sell |
11,951
-24,291
| -67% | -$95.5K | ﹤0.01% | 4962 |
|
2021
Q4 | $160K | Buy |
36,242
+25,693
| +244% | +$113K | ﹤0.01% | 4757 |
|
2021
Q3 | $65K | Sell |
10,549
-7,444
| -41% | -$45.9K | ﹤0.01% | 4973 |
|
2021
Q2 | $142K | Buy |
17,993
+3,405
| +23% | +$26.9K | ﹤0.01% | 4788 |
|
2021
Q1 | $156K | Buy |
+14,588
| New | +$156K | ﹤0.01% | 4219 |
|
2017
Q4 | – | Sell |
-564
| Closed | -$53K | – | 3582 |
|
2017
Q3 | $53K | Buy |
+564
| New | +$53K | ﹤0.01% | 3146 |
|
2017
Q1 | – | Sell |
-142
| Closed | -$22K | – | 3305 |
|
2016
Q4 | $22K | Buy |
142
+64
| +82% | +$9.92K | ﹤0.01% | 3061 |
|
2016
Q3 | $19K | Buy |
+78
| New | +$19K | ﹤0.01% | 2970 |
|
2016
Q2 | – | Sell |
-91
| Closed | -$82K | – | 2999 |
|
2016
Q1 | $82K | Sell |
91
-163
| -64% | -$147K | ﹤0.01% | 2869 |
|
2015
Q4 | $359K | Buy |
254
+163
| +179% | +$230K | ﹤0.01% | 2613 |
|
2015
Q3 | $153K | Buy |
+91
| New | +$153K | ﹤0.01% | 2983 |
|
2014
Q4 | – | Sell |
-327
| Closed | -$802K | – | 3252 |
|
2014
Q3 | $802K | Buy |
+327
| New | +$802K | ﹤0.01% | 2092 |
|